ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,942.47
      1.26%
      US Tech 100
      20,762.73
      1.73%
      Dow Jones
      42,732.13
      0.80%
      Brent Oil
      76.495
      0.00%
      Bitcoin
      97,885.95
      -0.32%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. UK
      5. LSE

      6. Medion Ag (0F7M) Quote

      Medion Ag

      Medion Ag (0F7M)

      LSE
      15.05
      0.00
      (0.00%)
      Closed January 05 11:30AM
      Delayed by 15 minutes

      Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

      Premium

      Key stats and details

      Current Price
      15.05
      Bid
      14.70
      Ask
      15.40
      Volume
      0.00
      0.00 Day's Range 0.00
      15.05 52 Week Range 15.05
      Market Cap
      672.449M
      Previous Close
      15.05
      Open
      -
      Last Trade
      (O)
      Last Trade Time
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      0.00
      Shares Outstanding
      44,681,000
      Dividend Yield
      -
      PE Ratio
      39.41
      Earnings Per Share (EPS)
      0.38
      Revenue
      752.01M
      Net Profit
      17.07M

      About Medion Ag

      Sector
      Computers & Software-whsl
      Industry
      Retail Trade (svc)
      Website
      www.medion.com
      Headquarters
      Essen, Deu
      Founded
      1983
      Medion Ag is listed in the Computers & Software-whsl sector of the London Stock Exchange with ticker 0F7M. The last closing price for Medion was 15.05 €. Over the last year, Medion shares have traded in a share price range of 15.05 € to 15.05 €.

      Medion currently has 44,681,000 shares outstanding. The market capitalization of Medion is 672.45 € million. Medion has a price to earnings ratio (PE ratio) of 39.41.

      Ask ADVFN Intelligence (AI)

      0F7M Latest News

      More News
      No news to show yet.
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10015.0515.0515.0500DE
      40015.0515.0515.0500DE
      120015.0515.0515.05015.05DE
      260015.0515.0515.05015.05DE
      520015.0515.0515.05015.05DE
      1560015.0515.0515.05015.05DE
      2600015.0515.0515.05615.05DE

      0F7M - Frequently Asked Questions (FAQ)

      What is the current Medion share price?
      The current share price of Medion is 15.05 €
      How many Medion shares are in issue?
      Medion has 44,681,000 shares in issue
      What is the market cap of Medion?
      The market capitalisation of Medion is EUR 672.45M
      What is the 1 year trading range for Medion share price?
      Medion has traded in the range of 15.05 € to 15.05 € during the past year
      What is the PE ratio of Medion?
      The price to earnings ratio of Medion is 39.41
      What is the cash to sales ratio of Medion?
      The cash to sales ratio of Medion is 0.89
      What is the reporting currency for Medion?
      Medion reports financial results in EUR
      What is the latest annual turnover for Medion?
      The latest annual turnover of Medion is EUR 752.01M
      What is the latest annual profit for Medion?
      The latest annual profit of Medion is EUR 17.07M
      What is the registered address of Medion?
      The registered address for Medion is AM ZEHNTHOF 77, ESSEN, 45307
      What is the Medion website address?
      The website address for Medion is www.medion.com
      Which industry sector does Medion operate in?
      Medion operates in the RETAIL TRADE (SVC) sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      TCFTheracryf Plc
      0.725p
      (38.10%)
      		7.56M
      NMTNeometals Ltd
      3.50p
      (27.27%)
      		346.81k
      SCHOScholium Group Plc
      44.00p
      (25.71%)
      		30.65k
      FABFusion Antibodies Plc
      10.15p
      (24.54%)
      		3.34M
      PYXPyx Resources Limited
      3.49p
      (22.24%)
      		8.43k
      TM1Technology Minerals Plc
      0.125p
      (-24.24%)
      		37.21M
      QUIZQuiz Plc
      0.70p
      (-18.60%)
      		3.67M
      SYMESupply@me Capital Plc
      0.003p
      (-17.81%)
      		168.35M
      OBDOxford Biodynamics Plc
      1.20p
      (-14.29%)
      		827.83k
      ZENZenith Energy Ltd.
      5.25p
      (-13.93%)
      		5.39M
      TRPTower Resources Plc
      0.0395p
      (5.33%)
      		539.51M
      CPXCap-xx Limited
      0.1825p
      (1.39%)
      		494M
      NTVONativo Resources Plc
      0.0019p
      (0.00%)
      		320.16M
      DGIDg Innovate Plc
      0.0225p
      (-13.46%)
      		208.21M
      ENETEthernity Networks Ltd
      0.1125p
      (2.27%)
      		207.56M

      Discussion

      View Full Feed
      boi568 boi568 6 minutes ago
      That spike to $31.50 was not organic and it was clearly generated by a big player. I have always thought it was an engineered mini-short squeeze.
      AVXL
      Mr. Bill Mr. Bill 18 minutes ago
      https://www.goodrx.com/well-being/sleep/how-to-sleep-with-sciatica
      nowwhat2 nowwhat2 20 minutes ago
      Could still just be climbing in sympathy w overall crypto mkt

      Scathingly poor outlooks

      https://www.youtube.com/watch?v=EOsjnOUAw14



      https://investorshub.advfn.com/uimage/uploads/2025/1/5/siwcoTOTAL_3_!_4_3M_JUNCT_DAY_1.jpg

      WONDF
      DonVance DonVance 22 minutes ago
      This will hit 1k this year I believe now.
      MSTR
      georgejjl georgejjl 23 minutes ago
      How many of the 7 million Alzheimer’s patients in the USA are projected to be treated with the MAB infusions during 2025???

      How many people with Alzheimer’s in the USA are projected to be treated with donepezil (Aricept) or memantine during 2025???

      The treatment used t
      AVXL
      Mr. Bill Mr. Bill 23 minutes ago
      Stretches https://www.healthline.com/health/back-pain/sciatic-stretches#sitting-spinal-stretch
      Graniteguy Graniteguy 25 minutes ago
      Doc and Investor posters here tend to be negatively biased which you whole heartedly champion, especially "Doc" who's medical opinion is at best questionable, and incredibly biased, to fit a narrative of constant failure for Anavex's Blarcamesine. The fact that you pile onto their "steaming pile of
      AVXL
      BDEZ BDEZ 27 minutes ago
      The Russes hit the jackpot?
      BDEZ BDEZ 28 minutes ago
      40% of homicides in the US take place in districts with a Soros-funded prosecutor.

      Biden gave him a Medal Of Freedom.

      https://x.com/EndWokeness/status/1875725808071012529
      BDEZ BDEZ 28 minutes ago
      Not good, thanks for sharing.
      sand sand 35 minutes ago
      Thank you Ducci for all your sharing and insights extremely helpful. I'm slowly diligently getting there rewiring the brain and focusing on what shows the moves. Much continued success this week. Thank you again.
      SPY
      mining101 mining101 35 minutes ago
      Moving hard soon 
      EFSH
      mining101 mining101 37 minutes ago
      Superb
      MEGL
      benz280c benz280c 44 minutes ago
      Speak louder and maybe you will convince somebody that this is how you really feel. No need to be insecure around your fellow investors.
      GDVM
      rx7171 rx7171 51 minutes ago
      In addition MABs are approved for only a limited portion of the AD population, whereas Blarcamasine appears to be effective in 70-80% of the ITT population with its strongest efficacy in the 70% with wild type Sigma-1.
      AVXL
      TheHound TheHound 51 minutes ago
      Learn how to use the bull market support band with that chart and you’ll have a powerful tool under your belt!
      XRPUSD
      Investor2014 Investor2014 55 minutes ago
      When I say that the totality of information is what Anavex rely on it does take into account the pretty ineffective SOC, associated risks and inconveniences for patients.

      Still any drug regulatory process must and should look carefully at the data to ensure that neither type one or tw
      AVXL
      nowwhat2 nowwhat2 1 hour ago
      Just learnt of the Total 3 today.......Appears to be a good thing to have learnt of.

      3 month
      https://investorshub.advfn.com/uimage/uploads/2025/1/5/siwcoTOTAL_3_!_4_3M_JUNCT_DAY_1.jpg



      Because how the overall mkt resolves itself is gonna'r have con
      BTCUSD
      rx7171 rx7171 1 hour ago
      Yes that spike to $23 in June of 2021 was driven entirely by the excellent Phase II data for PDD.

      Yet now after completing the AD 2b/3 trial and having an EMA MAA accepted for evaluation the share price is barely half that number!

      I understand the company being very ca
      PDD
      sunspotter sunspotter 1 hour ago
      Black Cat Moan was one of my favorites back in the day:

      https://youtu.be/cxN-frB1UbI?si=Ph6XMC3omR0rRlmR

      Edit: auto correct changed Moan to Moana. The cultural prevalence of Disney.
      Investor2014 Investor2014 1 hour ago
      The ex-biotech executive is back in the Rett trap posting mode - hope it goes better with the biased approach this time.

      Listing all the site PI’s is not world class peer review WGT confirmation.
      AVXL
      nowwhat2 nowwhat2 1 hour ago
      Just learnt of the Total 3 today.......Appears to be a good thing to have learnt of.

      3 month
      https://investorshub.advfn.com/uimage/uploads/2025/1/5/siwcoTOTAL_3_!_4_3M_JUNCT_DAY_1.jpg



      Because how the overall mkt resolves itself is gonna'r have con
      sunspotter sunspotter 1 hour ago
      I rather think you missed the point. It’s not that higher doses of GALT’s drug are toxic, it’s that they are ineffective.

      Given the purported mechanism, that almost certainly means lower doses are too, and that the implication that the lower dose worked is merely an artefact.
      GALT

      Your Recent History

      LSE
      0F7M
      Medion
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads